Academic Achievements

Fellows Recognition:

• Fawzi Abu Rous – Recipient of the 2023 Conquer Cancer Young Investigator Award
• Fawzi Abu Rous – Selected as member of the ASCO Trainee and Early Career Advisory Group 2022-2023
• Nino Balanchivadze – Selected as member of the ASH Trainee Council 2021-2022
• Fawzi Abu Rous – Selected for the FDA-ASCO Hematology & Oncology Fellows’ workshop 2022
• Fawzi Abu Rous – Recipient of the AACR-Doreen J. Putrah Cancer Research Foundation Scholar-in-Training Award 2022
• Rayli Pichardo – Selected for the FDA-ASCO Hematology & Oncology Fellows’ workshop 2022
• Sowjanya Vuyyala – Selected for the FDA-ASCO Hematology & Oncology Fellows’ workshop 2023
• Wei Zhao – Recipient of the AACR- Margaret Foti Foundation Scholar-in-Training Award 2023
• Luis Gonzalez – Selected for the Hemostasis and Thrombosis Trainee Workshop 2023
• Manasi Godbole – Recipient of the Cancer Advisory Group (CRAG) ACSO 2023 Travel Award from Henry Ford Cancer Institute Research Department.
• Radhika Kulkarni – First place in the poster session at the Henry Ford Medical Education Research Forum, May 2024
• Radhika Kulkarni – Recipient of the 2024 MSHO Travel Award.
• Radhika Kulkarni – Recipient of the ASH Medical Educators Institute(MEI) Award, 2024.
• Radhika Gutta – Selected for the FDA-ASCO Hematology & Oncology Fellows’ workshop, 2024.
• Muhammad Ali Shahid – Invitee for Onclive Roundtable Discussion: Prostate Cancer Evolving Treatments: Managing Advanced Prostate Cancer, March 2025

Publications

Gutta R, Teslow E, Jaeger E, Stoppler MC, Chao C, Rous FA, Potguari B, Gadgeel S. Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers. Clin Lung Cancer. 2025 Feb 14:S1525-7304(25)00038-5. doi: 10.1016/j.cllc.2025.02.008. Epub ahead of print. PMID: 40064574.

Kulkarni R, Zeine E, Potugari B, Gadgeel S, Montecalvo J, Rous FA. Small Cell Lung Cancer With de novo BRAF V600E Mutation and Durable Response to Targeted Therapy: A Case Report. Clin Lung Cancer. 2025 Feb 20:S1525-7304(25)00040-3. doi: 10.1016/j.cllc.2025.02.012. Epub ahead of print. PMID: 40133188.

Ghimire B, Zimmer M, Donthireddy V. TP53-Mutated Acute Myeloid Leukemia: Review of Treatment and Challenges. Eur J Haematol. 2025 Mar 4. doi: 10.1111/ejh.14404. Epub ahead of print. PMID: 40035191

Bachler JL, Khan GN, Wollner IS, Philip PA. Treatment of unresectable and resectable stage IV colorectal cancer. Clin Adv Hematol Oncol. 2024 Nov;22(9):455-463. PMID: 39509047.

Gonzalez-Mosquera LF, Rous FA, Rogers A, Smith N, Goyert G, Gadgeel S. ALK Rearrangement Positive Lung Adenocarcinoma in Pregnancy Treated With Alectinib: A Case Report. Clin Lung Cancer. 2023 Nov 17:S1525-7304(23)00241-3. doi: 10.1016/j.cllc.2023.11.006. Epub ahead of print. PMID: 38057186.

Godbole M, Wani K, Zia S, Dabak V. Carcinoma En Cuirasse: A Rare but Striking Cutaneous Manifestation of Metastatic Breast Cancer. June 1 2023. Cureus 15(6): e39838. doi:10.7759/cureus.39838

Abu Rous F, Singhi EK, Sridhar A, Faisal MS, Desai A. Cancer Invest. 2022. Lung Cancer Treatment Advances in 2022.

Francesca Coutinho, Zartash Gul, Anna B. Berry, Michael A. Thompson, Christopher A. Willner, et al. Molecular Biomarker Testing and Targeted Therapy Patterns in Patients with Acute Myelogenous Leukemia (AML) in Community Health Systems in the United States: A Real-World Data Analysis.Blood 2022.

Abu Rous F, Gutta R, Li P, Halmos B, Gadgeel S.Pembrolizumab in Combination with Chemotherapy in Patients with ERBB2-Mutated Non-Small Cell Lung Cancer. Target Oncol. 2022

Abu Rous F, Gutta R, Chacko R, Kuriakose P, Dabak V. Unusual Presentation of T-cell Large Granular Lymphocytic Leukemia.
Cureus, 2022

Maahs L, Ghanem AI, Gutta R, Tang A, Arya S, Al Saheli Z, Ali H, Chang S, Tam S, Wu V, Siddiqui F, Sheqwara J. Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy.
BMC Cancer. 2022

Muhammad Zain Farooq, Sheeba Ba Aqeel, Prasanth Lingamaneni, Rayli Pichardo, Aleeza Jawed, et al.Association of Immune Checkpoint Inhibitors With Neurologic Adverse Events: A Systematic Review and Meta-analysis. JAMA 2022

A L Schmidt, C Labaki, C-Y Hsu, Z Bakouny, Nino Balanchivadze, et al. COVID-19 vaccination and breakthrough infections in patients with cancer.Ann Oncol 2022

Abdel-Razeq H, Abu Rous F, Abuhijla F, Abdel-Razeq N, Edaily S.Breast Cancer in Geriatric Patients: Current Landscape and Future Prospects.
Clin Interv Aging, 2022

Bhatia M, Kak V, Patel P, Slota A.Thinking Beyond Bacterial Infection: A Case of Cutaneous Blastomycosis.Cureus, 2022

Fu J, Reid SA, French B, Hennessy C, Hwang C, Gatson NT, Duma N, Mishra S, Nguyen R, Hawley JE, Singh SRK, Chism DD, Venepalli NK, Warner JL, Choueiri TK, Schmidt AL, Fecher LA, Girard JE, Bilen MA, Ravindranathan D, Goyal S, Wise-Draper TM, Park C, Painter CA, McGlown SM, de Lima Lopes G Jr, Serrano OK, Shah DP; COVID-19 and Cancer Consortium (CCC19).Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer.JAMA Netw Open, 2022.

 

Abstracts and Posters

Muhammad A. Shahid, Radhika Gutta, Sunita Ghosh, Nallasivam Palanisamy.Co-mutations in FGFR3 and CDKN2A in bladder cancer: a descriptive analysis, AACR 2025. Cancer Res 15 April 2025; 85 (8_Supplement_1): 3400. https://doi.org/10.1158/1538-7445.AM2025-3400

Wei Zhao, Pin Li, Shannon Carskadon, Jessica Ryba, Hristina Trpevski, Vishnav Ramesh, Dhanajay Chitale, Firas Abdullah, Wooju Jeong, Craig Rogers, Nilesh Gupta, Nallasivam Palanisamy. Enhanced detection of molecular subtypes in prostate cancer using saturation biopsy: Insights into tumor heterogeneity and racial disparities. AACR 2025

Bipin Ghimire, Maria Jamil, Lisa R. Rogers, Marian Girgis. Efficacy of systemic therapy in breast cancer with CNS metastases: “Real-world” experience. ASCO 2025

Bipin Ghimire, Maria Jamil, Marian Girgis. Treatment and outcomes of breast cancer with leptomeningeal disease: Real-world experience in the African American population. ASCO 2025

Dhairya Gor, Maria Jamil, Sunita Ghosh, Vrushali Dabak. Sequencing of antibody drug conjugates(ADCs) in metastatic breast cancer : A Real-World Analysis. AACR 2025

Zimmer M, Jacob B, Spica M, Ghosh S, Dabak V. Outcomes of Acute Myeloid Leukemia Treated with a Hypomethylating Agent and Venetoclax: A Single Institution Analysis. AACR 2025.

Aroob Sweidan, Rachel L Brancamp, Ileana Lopez-Plaza, Gordon Jacobsen, Philip Kuriakose; Real World Data on the Utility of P-Selectin Expression Assay; Correlation of Test Results and Disease Expression. Blood 2024; 144 (Supplement 1): 1244. doi: https://doi.org/10.1182/blood-2024-207945

Zimmer M, Jacob B, Spica M, Ghosh S, Dabak V. Outcomes of Acute Myeloid Leukemia Treated with a Hypomethylating Agent and Venetoclax: A Single Institution Analysis. Blood 2024; 144 (Supplement 1): 6040. doi: https://doi.org/10.1182/blood-2024-205933

Radhika Kulkarni, Muhammad Ali Shahid, Oscar Hinojosa Castro, Kunj Patel, Chun-Hui Lin, Courtney Rose, Vrushali Dabak. “Abstract 2563: Understanding the New Subgroup- Her 2 Low Breast Cancer.” AACR 2024

Muhammad Ali Shahid,Radhika B. Kulkarni, Linda Albusoul, Brigid Jacob, Courtney M. Rose, Kylie Springer, and Vrushali S. Dabak .Evaluation and treatment response in patients with hormone receptor-positive, HER2 low metastatic breast cancer: A single center retrospective analysis. ASCO 2024. JCO 42, e13158-e13158(2024).DOI:10.1200/JCO.2024.42.16_suppl.e13158

Matthew Meranda, Madison Drallmeier, Sisira Kavuri, Jamie Abad, Aayush Mittal, Rida Farook, Muniza Hossain, Courtney Rose, Carl Wilson, Muhammad Shahid, Philip Kuriakose, Ahmad H. Mattour . The Mediating Effects of Racial and Social Health Disparities on Cancer Urgent Care Outcomes: An Urban Cancer Center Experience, ASH 2024. Blood 2024; 144 (Supplement 1): 2266. doi: https://doi.org/10.1182/blood-2024-194068

Radhika Kulkarni, Luis F. Gonzalez, Chun-Hui Lin, Courtney Rose, Josephine Emole, Asif Alavi, Edward Peres, Muneer H. Abidi, Shatha Farhan.Standard Risk Assessment Tools Fall Short to Assess Risk in Transplant Patients. ASTCT 2024. Transplantation and Cellular Therapy,Volume 30, Issue 2, Supplement,2024,Page S125,ISSN 2666-6367, https://doi.org/10.1016/j.jtct.2024.01.013.

Zaid Al-Saheli MBBS, Vrushali Dabak MD. Stretching the Boundary of Oncotype Dx Testing. AACR 2024

Muhammad Shahid DO, Linda Albusoul MD, Sruthi Ramanan MD, Radhika Gutta DO, Kylie Springer, Courtney Rose, Philip Kuriakose MD.Comprehensive Review of Patients with Hematologic Malignancies in a Cancer Urgent Care Center: A Single Center Experience. ASCO Quality Care Symposium 2023. JCO Oncol Pract 19, 144-144(2023). DOI:10.1200/OP.2023.19.11_suppl.144.

Radhika Kulkarni, Oscar Hinojosa, Vijayalakshmi Donthireddy; Real World Analysis of G6PD Testing Prior to the Use of Rasburicase in Hematologic Malignancies; A Single Center Experience. ASH 2023. Blood 2023; 142 (Supplement 1): 7332. doi: https://doi.org/10.1182/blood-2023-173264

Godbole M, Mary Nyhuis, Travis Washburn, JoAnn Hirth, Haythem Ali. PO4-08-02 Genetic testing among patients with triple-negative breast cancer at a single health system: a quality improvement project. SABCS 2023

Wani K, Godbole M, Jacob B, Springer K, Dabak V. PO5-15-08 Role of next-generation sequencing testing in metastatic breast cancer. SABCS 2023

Godbole M, Li Pin, Meranda M, Wani K, Gadgeel S. Characteristics and outcomes of small cell lung cancer (SCLC) patients detected with CT screening at a single health system. DOI: 10.1200/JCO.2023.41.16_suppl.8581 Journal of Clinical Oncology 41, no. 16_suppl (June 01, 2023) 8581-8581.

Godbole M, Meranda M, Shango K, Dabak VS. Lowering the bar for consideration of neoadjuvant chemotherapy in early-stage HER2-positive breast cancers. Journal of Clinical Oncology Volume 41, Number 16_suppl

Zaid Al-Saheli MBBS , Omar Ammari M.D , Linda Albusoul M.D. , Fawzi Abu Rous M.D. , Shirish Gadgeel M.D. Outcomes of Patients Diagnosed with Lung Cancer after COVID-19 Infection. NACLC,Chicago, 2023

Zimmer M, Bachler J, Sheqwara J. Klippel-Trenaunay Syndrome: a rare disorder with complex hemostatic and thrombotic challenges(Accepted poster presentation at International Society on Thrombosis and Haemostasis Congress, Bangkok, Thailand, June 2024)

Zimmer M, Donthireddy V. Bovine thrombin-associated antiphospholipid syndrome(Accepted poster presentation at International Society on Thrombosis and Haemostasis Congress, Bangkok, Thailand, June 2024)

Zimmer M, Jabbour H, Sheqwara J. May-Hegglin Anomaly: are giant platelets a giant problem?(Accepted poster presentation at International Society on Thrombosis and Haemostasis Congress, Bangkok, Thailand, June 2024)

Gonzalez-Mosquera, L. F., Neme, M. K., Mikulandric, N., Mazur, I., Emole, J., Alavi, A., ... & Farhan, S. Abatacept with FluBu2: To Use or Not to Use. Tandem Meetings,
Transplantation & Cellular Therapy Meeting. San Antonio, February 2024.

Kulkarni, R., Gonzalez-Mosquera, L.F., Abidi, M.H., Emole, J., Peres, E.M., Farhan,
S.Y. Standard Risk Assessment Tools Fall Short to Assess Risk in Transplant Patients.
American Society of Hematology (ASH), San Diego, December 2023 and Tandem Meetings, Transplantation & Cellular Therapy Meeting. San Antonio, February 2024.

Kulkarni R, Shahid M, Hinojosa Castro O, Patel K, Lin C, Rose C, Dabak V. Understanding the new subgroup- Her 2 low breast cancer. AACR 2024

Luis Gonzalez Mosquera, Nino Balanchivadze, Faria Ali, Matthew Meranda, Oscar Hinojosa Castro, Philip Kuriakose. Factors influencing career choices and post-fellowship perspectives in adult hematology/oncology physicians: A nationwide cross-sectional study. (Accepted for ASCO, 2024)

Luis Gonzalez Mosquera, Nino Balanchivadze, Faria Ali, Matthew Meranda, Oscar Hinojosa Castro, Philip Kuriakose. Factors influencing career choices and post-fellowship perspectives in adult hematology/oncology fellows: A nationwide cross-sectional study.(Accepted for ASCO, 2024)

Potugari B, Godbole M, Wani K, Meranda M, Rose C, Pin Li, Gadgeel S. Outcomes of small cell lung cancer with a small primary tumor size of 2cm or less. Poster presented at Targeted Therapied of Lung Cancer, Santa Monica CA 2024. Oral presentation in CE Concepts Small Cell Lung Cancer Young Investigators’ Forum in August 2023.Oral Presentations at OncLive National fellows forum

Zaid Al-Saheli MBBS , Omar Ammari M.D , Linda Albusoul M.D. , Fawzi Abu Rous M.D. , Shirish Gadgeel M.D. Outcomes of Patients Diagnosed with Lung Cancer after COVID-19 Infection. NACLC,Chicago, 2023.

Zaid Al-Saheli MBBS, Vrushali Dabak MD. Stretching the Boundary of Oncotype Dx Testing. AACR 2024

Satisfaction of hem/onc patients with video visits during the COVID-19 pandemic at a tertiary care center in Michigan
Authors: Fawzi Abu Rous, Pin Li, Mohamed Elgamal, Hussna Abunafessa, Rebecca Chacko, et al. 

For more information, visit https://scholarlycommons.henryford.com/hematologyoncology/